COVID-19: A Threat of Chronic Inflammatory Demyelinating Polyneuropathy Attack

Öz

Although COVID-19 has emerged as a disease affecting the respiratory system, increasing data show it is not limited to the respiratory system but also affects both the central and peripheral nervous systems. Since it affects many people and has been declared a pandemic, information about the course of the disease and the treatment plan during and/or after COVID-19 in patients with chronic neurological disease is becoming increasingly important. A 42-year-old male patient who was hospitalized in the infectious diseases service because of being COVID-19 positive was evaluated with difficulty breathing and swallowing and weakness in four extremities. On neurological examination, muscle strength was 3/5 in all four extremities according to the Medical Research Council (MRC) scale, and there was widespread hypoesthesia in all four extremities. Deep tendon reflexes were completely absent. The first complaints of our patient started six years ago, and the diagnosis of CIDP was made two years after the first complaint, with typical clinical features and electrophysiological findings. In this case report, we share a patient with COVID-19 and chronic inflammatory demyelinating polyneuropathy (CIDP), and we aim to report the clinical worsening of CIDP with COVID-19.

Anahtar Kelimeler

• CIDP
• COVID-19
• polyneuropathy attack

COVİD-19: Kronik İnflamatuar Demiyelinizan Polinöropati Atağı İçin Bir Tehdit

Öz

COVID-19 solunum sistemini etkileyen bir hastalık olarak ortaya çıkmış olsa da, artan veriler solunum sistemi ile sınırlı olmadığını, hem merkezi hem de periferik sinir sistemini de etkilediğini göstermektedir. Pandemi olarak ilan edilmesi ve birçok insanı etkilemesi nedeniyle, kronik nörolojik hastalığı olan hastalarda COVID-19 sırasında ve/veya sonrasında hastalığın seyri ve tedavi planı ile ilgili bilgiler giderek önem kazanmaktadır. COVID-19 pozitif olması nedeniyle enfeksiyon hastalıkları servisine yatırılan 42 yaşındaki erkek hasta, solunum ve yutma güçlüğü, dört ekstremitede güçsüzlük şikayeti ile değerlendirildi. Nörolojik muayenesinde dört taraflı kas gücü 3/5 ve dört ekstremitede yaygın hipoestezi saptandı. Derin tendon refleksleri genellikle yoktu. Hastamızın ilk şikayetleri 6 yıl önce başlamış, tipik klinik özellikleri, elektrofizyolojik bulguları sonucunda 2 yıl sonra CIDP tanısı konmuştu. Bu vaka raporunda, COVID-19 ve kronik inflamatuar demiyelinizan polinöropatili (KİDP) bir hastayı paylaşıyoruz ve COVID-19 ile KİDP'nin klinik kötüleşmesini bildirmeyi amaçladık.

Anahtar Kelimeler

• CIDP
• COVID-19
• polinöropati atağı

Kaynakça

1. 1. Mathey K. E, Park B. S, Hughes A.C. R, Pollard D. J, Armati J. P, Barnett H. M, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry 2015;86:973-985.
2. 2. Moriquchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. International Journal of Infectious Diseases 2020;94:55-58.
3. 3. Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med 2020; 38:1549.e3-1549.e7.
4. 4. Abu-Rumeileh S, Garibashvili T, Ruf Wolfgang, Fangerau T, Kassubek J, Althaus K, et al. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. J Neurol Sci 2020; 418: 117106.
5. 5. Paybast S, Gorji R, Mavandadi S. Guillain-Barre Syndrome as a Neurological Complication of Novel COVID-19 Infection: A Case Report and Review of the Literature. Neurologist 2020;25:1-18.
6. 6. Patel D, Mandal G, Chukwueke L, Woods K. A Rare Case of COVID-19-Induced Chronic Demyelinating Polyneuropathy. Cureus. 2022 ;14(5):e25165.
7. 7. Abu-Rumeileh S, Garibashvili T, Ruf W, Fangerau T, Kassubek J, Althaus K, Otto M, Senel M. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. J Neurol Sci. 2020;418:117106.
8. 8. 8.Van Looy E, Veenker L, Steyaert A, Leenders J, Malfroid G, De Cauwer H. COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy. J Neurol. 2021:3129-3131.